Chris is a Director and founder of Cofactor Group. His healthcare experience includes leading engagements in launch preparedness, opportunity assessment and lifecycle strategy, market access strategy, forecasting, and brand planning.
Prior to founding Cofactor Group, Chris was a consultant in the Health Care Practice and Arthur D. Little, a global strategy consulting firm, and a Product Manager for Empire Blue Cross and Blue Shield. Chris holds a Bachelor of Science in Business Administration from Georgetown University.
Cofactor partnered with a biotechnology organization to inform critical investment decisions about a potential treatment for SARS-CoV-2 infection.
Co-commercialization or co-promotion agreements have become the new norm in the life sciences industry, and all have one thing in common - they are challenging. Cofactor provides specific alliance expertise, capabilities, and tools that can help your alliance work more effectively.